Abstract:Abstract Background The traditional audiovisual sexual stimulation (AVSS) test may experience limitations including low erectile response rate and lack of unified diagnostic criteria. Aim We aimed to explore the clinical value of AVSS with virtual reality (VR-AVSS) test in assessing erectile function and diagnosing erectile dysfunction (ED). Methods Participants 18 to 60 years of age were screened for analysis in 3 clinical centers from June 2020 to March 2022. Demographic data, 5-item International Index of Erectile Function (IIEF-5), erectile hardness score (EHS), and self-reported symptom questions were collected. The ED patients and control patients were confirmed according to the IIEF-5 and EHS. All subjects watched a 60-minute erotic video by VR device during RigiScan recording. The parameters including tip average rigidity, tip effective erectile duration (duration of rigidity ≥60%, tip effective erectile duration), base average rigidity, and base effective erectile duration were evaluated. Outcomes The main outcome of interest was the application of VR immersion technology to improve the traditional AVSS test. Results A total of 301 ED cases and 100 eligible control patients were included for final analysis. Compared with control patients, ED cases had significantly lower IIEF-5 scores, EHS, positive response rate, and erectile rigidity and duration. The positive response rate of ED and control patients were 75.5% and 90.9%, respectively. The cutoff points of tip average rigidity, tip effective erectile duration, base average rigidity, and base effective erectile duration were 40.5% (sensitivity: 77.6%, specificity: 70.2%; P < .001), 4.75 minutes (sensitivity: 75.9%, specificity: 75.4%; P < .001), 48.5% (sensitivity: 77.6%, specificity: 75.1%; P < .001), and 7.75 minutes (sensitivity: 79.3%, specificity: 75.7%; P < .001). Clinical Implications The technological superiority of VR will enable the VR-AVSS immersion test to be a more accurate detection than traditional AVSS modes. Strengths and Limitations Our study applied VR immersion technology to establish the standard operation procedure for the AVSS test, which could effectively reduce the interference of adverse factors and minimize the detecting errors. However, the test data only included positive response subjects, so the true erectile status of men with a negative response to the AVSS test cannot be obtained. Conclusions The VR-AVSS test can effectively improve the diagnostic accuracy of ED. The average rigidity and effective erectile duration were the optimal diagnostic parameters for excluding ED.

Efficacy of audiovisual sexual stimulation combined with intracavernous injection of alprostadil in monitoring penile rigidity of patients with erectile dysfunction

[Real-Time Rigiscan Monitoring and Color Doppler Ultrasonography in the Diagnosis of Erectile Dysfunction].

Dynamic Observation of Penile Hemodynamic Change in Patients with Vasculogenic Erectile Dysfunction after Prostaglandin E1 Treatment

The diagnostic value of audiovisual sexual stimulation (AVSS) on erectile dysfunction

[Pde-5I Combined with RigiScan-based Audiovisual Sexual Stimulation Test Versus Nocturnal Penile Tumescence Test in Evaluation of Erectile Function].

The value of audiovisual sexual stimulation with virtual reality in diagnosing erectile dysfunction

Intracaverous injection of aloprostadil sterile power (prostaglandin E1,caverject) for treatment of erectile dysfunction: a 8-Years experience

AB029. The clinical significance of RigiScan plus detection

Study on the hemodynamic parameters of the erection penis evoked by Sildenaifl combined with audio-visual sexual stimulation

AB044. Initial Analysis of PDE5i and Visual-Auditory Sexual Stimulation Rigiscan Plus Detection Results of 1,896 Cases in Outpatients

[RigiScan monitoring assists tadalafil medication in the treatment of penile ED]

A novel strategy to induce penile erection during penile doppler ultrasound: oral sildenafil administration plus alprostadil injection

Application of audio-visual sexual stimulation and education in the treatment of erectile dysfunction with sildenafil

The patient's self-evaluation better predicts the degree of erectile dysfunction than the response to intracavernous alprostadil testing

Role of RigiScan parameters in differentiation of vascular erectile dysfunction

Intracavernous Pressure Responses Induced by Electrical Stimulation of Penile Dorsal Nerves and Intracavernosal Drug Injection in Rats

Physiological interrelationships between the venous shunts of penile corpus spongiosum and cavernous compartments during erection used in the pharmacotherapy of erectile dysfunction

(268) Intracavernous Prostaglandin Injection as a Predictor and Effectiveness Measure for LISWT Sessions in ED Patients: A Single Urologist's Experience

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Effect of Intracavernosal Injection of Prostaglandin E1 on Duration and Rigidity of Erection in Patients With Vasculogenic Erectile Dysfunction: Is It Dose Dependent?

Why a combined intracavernosal injection with trimix and oral sildenafil is reliable therapy in the ultrasonographic evaluation of erectile dysfunction